BCL2L1 and hepatocellular carcinoma: Meanwhile, we observed that in hepatitis-related HCC, patients with higher expression of BCL2L1, EGFR, ESR1, HNF4A, MAPK8, and PTEN, and lower expression of HDAC1 had a better clinical prognosis.